SCHEMBL1784610

SCHEMBL1784610

CCCCCC=CCCC(C)=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.61
PPARD Q03181 4/20 0.61
PPARA Q07869 4/20 0.61
TERT O14746 3/20 0.61
PTPN1 P18031 3/20 0.61
MAPT P10636 3/20 0.61
BLM P54132 3/20 0.61
HSD17B10 Q99714 3/20 0.61
FABP4 P15090 3/20 0.61
KMT2A Q03164 3/20 0.61
TOP1 P11387 3/20 0.61
CYP1A2 P05177 2/20 0.61
CYP2C19 P33261 2/20 0.61
FAAH O00519 2/20 0.61
USP2 O75604 2/20 0.61
LMNA P02545 2/20 0.61
ALOX15 P16050 2/20 0.61
RECQL P46063 2/20 0.61
CYP19A1 P11511 2/20 0.61
NR4A2 P43354 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11502529 1.00 PPARG (0.61) PPARGPPARDPPARATERTPTPN1
SCHEMBL1784609 1.00 PPARG (0.61) PPARGPPARDPPARATERTPTPN1
SCHEMBL1783654 0.98 TERT (0.64) PPARGPPARDPPARATERTPTPN1
SCHEMBL1783060 0.98 TERT (0.64) PPARGPPARDPPARATERTPTPN1
SCHEMBL1784621 0.98 TERT (0.64) PPARGPPARDPPARATERTPTPN1
SCHEMBL1783702 0.98 TERT (0.64) PPARGPPARDPPARATERTPTPN1
SCHEMBL1782209 0.98 TERT (0.64) PPARGPPARDPPARATERTPTPN1
SCHEMBL1783700 0.98 TERT (0.64) PPARGPPARDPPARATERTPTPN1
SCHEMBL1784194 0.98 TERT (0.64) PPARGPPARDPPARATERTPTPN1
SCHEMBL11705619 0.98 TERT (0.64) PPARGPPARDPPARATERTPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-54019908-A None JP disclosed
CN-112430453-B Cooling liquid composition and cooling system 丰田自动车株式会社 2022-06-14 CN disclosed
CN-112430453-A Cooling liquid composition and cooling system 丰田自动车株式会社 2021-03-02 CN disclosed
US-20170362533-A1 ENAMINE AND/OR AMINAL FRAGRANCE PRECURSORS DERIVED FROM (E/Z)-9-HYDROXY-5,9-DI-METHYLDEC-4-ENAL GIVAUDAN S.A. (CH) 2017-12-21 US disclosed
US-9573872-B2 Using mixtures of E/Z isomers to obtain quantitatively specific products by combining asymmetric hydrogenation and isomerization DSM IP ASSETS B.V. (NL) 2017-02-21 US disclosed
US-9458076-B2 Using mixtures of E/Z isomers to obtain quantitatively specific products by combined asymmetric hydrogenations DSM IP ASSETS B.V. (NL) 2016-10-04 US disclosed
US-20160185702-A1 USING MIXTURES OF E/Z ISOMERS TO OBTAIN QUANTITATIVELY SPECIFIC PRODUCTS BY COMBINING ASYMMETRIC HYDROGENATION AND ISOMERIZATION DSM IP ASSETS B.V. (NL) 2016-06-30 US disclosed
US-20150321986-A1 USING MIXTURES OF E/Z ISOMERS TO OBTAIN QUANTITATIVELY SPECIFIC PRODUCTS BY COMBINED ASYMMETRIC HYDROGENATIONS DSM IP ASSETS B.V. (NL) 2015-11-12 US disclosed
US-9181163-B2 Hydrogenation of ketones having at least a carbon-carbon double bond in the γ,δ-position DSM IP ASSETS B.V. (NL) 2015-11-10 US disclosed
US-20140249321-A1 HYDROGENATION OF KETONES HAVING AT LEAST A CARBON-CARBON DOUBLE BOND IN THE y, -POSITION DSM IP ASSETS B.V. (NL) 2014-09-04 US disclosed
EP-2720996-A1 HYDROGENATION OF KETONES HAVING AT LEAST A CARBON-CARBON DOUBLE BOND IN THE , -POSITION DSM IP Assets B.V. (NL) 2014-04-23 EP disclosed
US-8632792-B2 Cooling sensation agent composition and sensory stimulation agent composition TAKASAGO INTERNATIONAL CORPORATION (JP) 2014-01-21 US disclosed
WO-2012171969-A1 HYDROGENATION OF KETONES HAVING AT LEAST A CARBON-CARBON DOUBLE BOND IN THE γ, δ-POSITION DSM IP ASSETS B.V. (NL) 2012-12-20 WO disclosed
EP-2535323-A1 Hydrogenation of ketones having at least a carbon-carbon double bond in the gamma-,delta-position DSM IP Assets B.V. (NL) 2012-12-19 EP disclosed
US-20110117147-A1 COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-05-19 US disclosed
WO-2009123355-A2 COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2009-10-08 WO disclosed
EP-1687301-A1 THIAEPOTHILONE FOR TREATING CANCEROUS DISEASES LEIBNIZ-INSTITUT FÜR PFLANZENBIOCHEMIE (IPB) (DE) 2006-08-09 EP disclosed
WO-2005051947-A1 THIAEPOTHILONE FOR TREATING CANCEROUS DISEASES LEIBNIZ-INSTITUT FÜR PFLANZENBIOCHEMIE (IPB) (DE) 2005-06-09 WO disclosed
US-4349626-A Method of detecting Pseudomonas aeruginosa infections utilizing selected ketone and/or sulfur metabolites THE MONELL CHEMICAL SENSES CENTER (US) 1982-09-14 US disclosed
JP-S5419908-A PREPARATION AND USE OF CIS-5-UNDECEN-2-ONE AND ITS NOVEL INTERMEDIATE T HASEGAWA CO LTD 1979-02-15 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170362533-A1 ENAMINE AND/OR AMINAL FRAGRANCE PRECURSORS DERIVED FROM (E/Z)-9-HYDROXY-5,9-DI-METHYLDEC-4-ENAL HNMT, DRD5, H1-5 PPARG 1844/4885PPARD 419/4885PPARA 972/4885
US-20140249321-A1 HYDROGENATION OF KETONES HAVING AT LEAST A CARBON-CARBON DOUBLE BOND IN THE y, -POSITION VKORC1, VKORC1L1, CBR1 PPARG 1167/4885PPARD 647/4885PPARA 1288/4885
US-20110117147-A1 COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION TRPA1, HRH1, HRH2 PPARG 1977/4885PPARD 2480/4885PPARA 1799/4885
US-20150321986-A1 USING MIXTURES OF E/Z ISOMERS TO OBTAIN QUANTITATIVELY SPECIFIC PRODUCTS BY COMBINED ASYMMETRIC HYDROGENATIONS EPHX2, HBZ, ELOVL5 PPARG 292/4885PPARD 431/4885PPARA 271/4885
US-20160185702-A1 USING MIXTURES OF E/Z ISOMERS TO OBTAIN QUANTITATIVELY SPECIFIC PRODUCTS BY COMBINING ASYMMETRIC HYDROGENATION AND ISOMERIZATION EPHX2, ZDHHC2, GNE PPARG 269/4885PPARD 423/4885PPARA 281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.